<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Site da Brakke Consulting</provider_name><provider_url>https://brakkeconsulting.com/pt</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="hdzoUnMBfa"&gt;&lt;a href="https://brakkeconsulting.com/pt/14182/"&gt;Not&#xED;cias e notas sobre sa&#xFA;de animal de 14 de fevereiro de 2003&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/pt/14182/embed/#?secret=hdzoUnMBfa" width="600" height="338" title="&#x201C;Animal Health News &amp; Notes for February 14, 2003&#x201D; &#x2014; Brakke Consulting Website" data-secret="hdzoUnMBfa" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>****************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 14, 2003 Copyright &copy; Brakke Consulting, Inc. ****************************************************************** COMPANY EARNINGS RELEASES &gt;&nbsp; Virbac SA announced provisional turnover for the year 2002 was 367 million euros ($388 million), an increase of 5% over 2001.&nbsp; The companion animal business grew 10% reinforced by sales of new products.&nbsp; The animal feed business recorded a 3% decrease following Virbac&rsquo;s decision to reduce this activity in Brazil.&nbsp; (Animal Pharm) &gt;&nbsp; Dainippon reported net sales of 12.4 billion yen ($103 million) for its animal science division for the first half of the fiscal year.&nbsp; Sales through September 30, 2002 showed a 6.5% increase over the comparable period in the prior year. (Animal Pharm) &gt;&nbsp; Heska reported financial results for the year ended December 31, 2002.&nbsp; Total companion animal health product sales for the year were up 10% to $35.9 million, while total food animal health product sales for the year were up 4% to $14.2 million.&nbsp; (company press release) &gt;&nbsp; Evialis reported turnover for the first nine months of 2002 were 552 million euros ($589 million) a decrease of 5.7%.&nbsp; Third quarter turnover fell to 168 million euros ($179 million) compared with 180 million euros in the prior year third quarter. The downturn in demand for the company&rsquo;s main product range was partially offset by theView Full Post;</description></oembed>
